The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2022 | Remaining challenges prior to the implementation of EV-based noninvasive testing
Atocha Romero, PharmD, PhD, Hospital Universitario Puerta de Hierro, Madrid, Spain, provides an overview of the remaining challenges prior to the implementation of extracellular vesicles-based noninvasive testing, including characterization of the vesicles containing the biomarker of interest and the development of high-throughput technology to capture the vesicles. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.
